Antithrombotic therapy in valvular heart disease.
D001024:Aortic Valve Stenosis / Q000150:complications; D002114:Calcinosis / Q000150:complications; D002986:Clinical Trials as Topic; D004697:Endocarditis, Bacterial / Q000150:complications; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006349:Heart Valve Diseases / Q000150:complications*; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006801:Humans; D008945:Mitral Valve Prolapse / Q000150:complications; D008946:Mitral Valve Stenosis / Q000150:complications; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000517:prevention & control; D012214:Rheumatic Heart Disease / Q000150:complications; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D005343:Fibrinolytic Agents